ConductScience.org, home

Paper20031382

Add-on montelukast in inadequately controlled asthma patients in a 6-month open-label study: the MONtelukast In Chronic Asthma (MONICA) study.

Virchow JC and 4 others. Respir Med, 2010. Cited by 33 papers, by iCite.

Cite this record

ConductScience Library. Add-on montelukast in inadequately controlled asthma patients in a 6-month open-label study: the MONtelukast In Chronic Asthma (MONICA) study. Papers, record 20031382. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20031382

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Add-on montelukast in inadequately controlled asthma patients in a 6-month open-label study: the MONtelukast In Chronic Asthma (MONICA) study.
PubMed
Journal
Respir Med
PubMed
Year
2010
PubMed
Publication types
Journal Article, Multicenter Study, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
33
iCite
Relative citation ratio, by iCite
1.05
iCite
Revised in PubMed
2026-05-18
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Virchow JCJ Christian
2Mehta AAnish
3Ljungblad LLi
4Mitfessel HHarald
5MONICA study groupGroup

Source PubMed

Download CSV of authors

Topics19

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AcetatesMajor topic
Adrenergic beta-AgonistsMajor topic
Anti-Asthmatic AgentsMajor topic
AsthmaMajor topic
QuinolinesMajor topic
Adult
Cyclopropanes
Dose-Response Relationship, Drug
Drug Therapy, Combination
Female
Humans
Male
Middle Aged
Prospective Studies
Quality of Life
Sulfides
Surveys and Questionnaires
Treatment Outcome
Young Adult

Source PubMed

Download CSV of topics

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT00802789Montelukast in Chronic AsthmaResultsYes

Source ClinicalTrials.gov

Download CSV of trials

Cited by15

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 33 citations.

PMIDTitleJournalYearIn PapersSource
39953492Effect of add-on therapy with leukotriene receptor antagonists and Chungsangboha-tang in patients with asthma: a protocol for a randomized, placebo-controlled, parallel, multicenter trial.BMC Complement Med Ther2025https://conductscience.org/library/papers/39953492PubMed
34434103Phosphodiesterase-4 Inhibitors for Non-COPD Respiratory Diseases.Front Pharmacol2021https://conductscience.org/library/papers/34434103PubMed
34403097Effects of Medication Use on Small Airway Function and Airway Inflammation in Patients with Clinically Controlled Asthma.Curr Med Sci2021https://conductscience.org/library/papers/34403097PubMed
33173647Role of Montelukast as Monotherapy in Improving Quality of Life of an Asthmatic Patient in Pakistan.Cureus2020https://conductscience.org/library/papers/33173647PubMed
32727032The Hidden Burden of Severe Asthma: From Patient Perspective to New Opportunities for Clinicians.J Clin Med2020https://conductscience.org/library/papers/32727032PubMed
31501737Role of Montelukast in Improving Quality of Life in Patients with Persistent Asthma.Cureus2019https://conductscience.org/library/papers/31501737PubMed
31258585Effectiveness and Quality of Life with Montelukast in Asthma - A double-blind randomized control trial.Pak J Med Sci2019https://conductscience.org/library/papers/31258585PubMed
29256220Add-on Therapy for Symptomatic Asthma despite Long-Acting Beta-Agonists/Inhaled Corticosteroid.Tuberc Respir Dis (Seoul)2018https://conductscience.org/library/papers/29256220PubMed
27499820Efficacy and Safety of Modified Pranlukast (Prakanon(®)) Compared with Pranlukast (Onon(®)): A Randomized, Open-Label, Crossover Study.Open Respir Med J2016https://conductscience.org/library/papers/27499820PubMed
27275233The Effect of Combined Therapy ICS/LABA and ICS/LABA plus Montelukast in Patients with Uncontrolled Severe Persistent Asthma Based on the Serum IL-13 and FEV1.Open Access Maced J Med Sci2015https://conductscience.org/library/papers/27275233PubMed
26528362Approach to Patients with Severe Asthma: a Consensus Statement from the Respiratory Care Experts' Input Forum (RC-EIF), Iran.Tanaffos2015https://conductscience.org/library/papers/26528362PubMed
26122504Addition of Montelukast to Low-Dose Inhaled Corticosteroid Leads to Fewer Exacerbations in Older Patients Than Medium-Dose Inhaled Corticosteroid Monotherapy.Allergy Asthma Immunol Res2015https://conductscience.org/library/papers/26122504PubMed
26122501More Effective Strategies are Needed for Elderly Asthmatics in Real-World Practice.Allergy Asthma Immunol Res2015https://conductscience.org/library/papers/26122501PubMed
25948889Guidelines for diagnosis and management of bronchial asthma: Joint ICS/NCCP (I) recommendations.Lung India2015https://conductscience.org/library/papers/25948889PubMed
23251741Montelukast in asthma: a review of its efficacy and place in therapy.Ther Adv Chronic Dis2011https://conductscience.org/library/papers/23251741PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/20031382

GET https://conductscience.org/api/papers/v1/20031382/authors